Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1997 | 03-1997 | 12-1996 | 09-1996 | 06-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,198 | -5,929 | -32,420 | -24,581 | -15,392 |
| Depreciation Amortization | 2,546 | 1,201 | 6,080 | 4,514 | 3,066 |
| Other Working Capital | -2,171 | -422 | -8,550 | -10,698 | -7,243 |
| Other Operating Activity | 2,359 | 1,790 | 14,610 | 10,558 | 6,359 |
| Operating Cash Flow | $-7,464 | $-3,360 | $-20,280 | $-20,207 | $-13,210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,085 | -1,184 | -8,620 | -8,015 | -7,462 |
| Other Investing Activity | -15,638 | -969 | -35,680 | -23,840 | -20,908 |
| Investing Cash Flow | $-16,723 | $-2,153 | $-44,300 | $-31,855 | $-28,370 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 41,157 | -1,048 | 66,320 | 56,799 | 57,694 |
| Financing Cash Flow | $41,157 | $-1,048 | $66,320 | $56,799 | $57,694 |
| Beginning Cash Position | 34,475 | 34,475 | 32,730 | 32,736 | 32,736 |
| End Cash Position | 51,445 | 27,914 | 34,470 | 37,453 | 48,850 |
| Net Cash Flow | $16,970 | $-6,561 | $1,730 | $4,717 | $16,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,464 | -3,360 | -20,280 | -20,207 | -13,210 |
| Free Cash Flow | -7,464 | -3,360 | -20,280 | -20,207 | -13,210 |